Cargando…
EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK
Autores principales: | Brown, C., Archer, M., Carson, L., Collins, N., Daniels, T., Gates, A., Johnstone, Z., Patel, N., Rashid, R., Whitehouse, J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192140/ http://dx.doi.org/10.1016/S1569-1993(21)01000-6 |
Ejemplares similares
-
EPS1.04 Audit of virtual exercise class during COVID-19 in children with cystic fibrosis
por: Johnstone, Z., et al.
Publicado: (2021) -
EPS1.05 Evaluating impacts of the change from clinic to home spirometry on clinicians and adults with cystic fibrosis
por: Daniels, T., et al.
Publicado: (2021) -
EP02 A rare case of Reactive arthritis secondary to COVID-19
por: Sidhu, Arslan, et al.
Publicado: (2020) -
EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics
por: Scott, E., et al.
Publicado: (2021) -
EPS1.01 Physiotherapy practice of French cystic fibrosis children changed during lockdown due to COVID-19 pandemic
por: Mittaine, M., et al.
Publicado: (2021)